These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Reactions of immunoglobulin G-binding ligands with platelets and platelet-associated immunoglobulin G. Rosse WF; Devine DV; Ware R J Clin Invest; 1984 Feb; 73(2):489-96. PubMed ID: 6699173 [TBL] [Abstract][Full Text] [Related]
43. Studies of cryoprecipitates from synovial fluid of rheumatoid patients. Cracchiolo A; Goldberg LS; Barnett EV; Bluestone R Immunology; 1971 Jun; 20(6):1067-77. PubMed ID: 4997575 [TBL] [Abstract][Full Text] [Related]
44. Further studies of the human platelet receptor for quinine- and quinine-dependent antibodies. Kunicki TJ; Russell N; Nurden AT; Aster RH; Caen JP J Immunol; 1981 Feb; 126(2):398-402. PubMed ID: 7451983 [TBL] [Abstract][Full Text] [Related]
45. Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL) patients during the first two to four years of DDS treatment. Melsom R; Harboe M; Naafs B Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):271-81. PubMed ID: 6754639 [TBL] [Abstract][Full Text] [Related]
50. The effects of aggregated immunoglobulins on human blood platelets in relation to their complement-fixing abilities. I. Studies of immunoglobulins of different types. Pfueller SL; Lüscher EF J Immunol; 1972 Sep; 109(3):517-25. PubMed ID: 5066345 [No Abstract] [Full Text] [Related]
51. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders. Clofent-Sanchez G; Laroche-Trainean J; Lucas S; Rispal P; Pellegrin JL; Nurden P; Nurden A Hum Antibodies; 1997; 8(2):50-9. PubMed ID: 9289388 [TBL] [Abstract][Full Text] [Related]
52. Thrombasthenic-thrombopathic thrombocytopenia with giant, "swiss-cheese" platelets. A case report. Smith TP; Dodds WJ; Tartaglia AP Ann Intern Med; 1973 Dec; 79(6):828-34. PubMed ID: 4586817 [No Abstract] [Full Text] [Related]
53. Platelet immunology. Symposium on Platelet Immunology: Actuality. Paris, France, March 20, 1987. Proceedings. Curr Stud Hematol Blood Transfus; 1988; (55):1-188. PubMed ID: 3365993 [No Abstract] [Full Text] [Related]
54. [Attempt at classifying specific thrombocyte antigens 11th communication: the evidence of the platelet antigen 5a (author's transl)]. Májský A Z Immunitatsforsch Exp Klin Immunol; 1973 May; 145(3):214-8. PubMed ID: 4283264 [No Abstract] [Full Text] [Related]
55. Comparison of certain properties of naturally occurring low molecular weight Gamma M and the Gamma M monomer derived by reduction and alkylation of 19S Gamma M. Swedlund HA; Gleich GJ; Chodirker WB J Immunol; 1968 Jun; 100(6):1296-303. PubMed ID: 4972187 [No Abstract] [Full Text] [Related]
56. [Anti-platelet antibodies in patients with autoimmune disorders]. Kurata Y Rinsho Ketsueki; 1993 May; 34(5):593-8. PubMed ID: 8315830 [TBL] [Abstract][Full Text] [Related]
57. Humanized mouse models of FcR clearance in immune platelet disorders. McKenzie SE Blood Rev; 2002 Mar; 16(1):3-5. PubMed ID: 11913983 [TBL] [Abstract][Full Text] [Related]
58. Techniques for detection and clinical significance of platelet antibodies. De Gaetano G; Vermylen J; Verstraete M Farmaco Prat; 1973 Oct; 28(10):497-506. PubMed ID: 4769269 [No Abstract] [Full Text] [Related]
59. [Thrombocyte antibodies. Clinical significance and a new method of membrane-bound antibodies]. Hansen OP; Hippe E Ugeskr Laeger; 1983 Oct; 145(40):3077-82. PubMed ID: 6359619 [No Abstract] [Full Text] [Related]
60. A comparative study on the solid phase capture--platelet test, platelet adhesion immunofluorescence test and lymphocytotoxic test. Jin J; Lin XJ; Dorner R; Sachs V Chin Med J (Engl); 1993 Jul; 106(7):533-7. PubMed ID: 8243126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]